Archive for category: Contract Awards

Ampersand Biosciences awarded SBIR Grant for Immunologic Analysis of Non-Mammalian and Underrpresented Mammalian Models

September 30, 2024/in Contract Awards

Ampersand Biosciences was cited in the article titled, “Dipeptidyl peptidase-4 inhibitor linagliptin reduces inflammatory response, ameliorates tissue edema formation, and improves survival in severe sepsis” for measuring cytokine and chemokine content in plasma samples that could measure drug exposure in mice of linagliptin, a DDP-4 (dipeptidyl peptidase-4) ihibitor.

Species: Mouse

Focus: Sepsis induced pro-inflammatory cytokine and chemokine production.

Ampersand Biosciences awarded a contract by the NIAID for the development of Ferret Reagents for us in the characterization of immune responses to respiratory infections in the ferret model

July 1, 2020/in Contract Awards

Ampersand Biosciences was cited in the article titled, “Dipeptidyl peptidase-4 inhibitor linagliptin reduces inflammatory response, ameliorates tissue edema formation, and improves survival in severe sepsis” for measuring cytokine and chemokine content in plasma samples that could measure drug exposure in mice of linagliptin, a DDP-4 (dipeptidyl peptidase-4) ihibitor.

Species: Mouse

Focus: Sepsis induced pro-inflammatory cytokine and chemokine production.